NCT02022514View on ClinicalTrials.gov

Intracoronary Infusion of Mononuclear Cells Autologous Bone Marrow in Patients With Chronic Coronary Occlusion and Ventricular Dysfunction, Previously Revascularized.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions
Coronary Atherosclerosis and Other Heart Disease
Interventions
OTHER

Mononuclear cells from autologous bone marrow

Mononuclear bone marrow cells autologous intracoronary

DRUG

Conventional medical treatment

Trial Locations (2)

11009

Dr. Alejandro Gutierrez, Cadiz

14004

Hospital U. Reina Sofía, Seville

All Listed Sponsors
collaborator

Iniciativa Andaluza en Terapias Avanzadas

OTHER

lead

Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud

OTHER

NCT02022514 - Intracoronary Infusion of Mononuclear Cells Autologous Bone Marrow in Patients With Chronic Coronary Occlusion and Ventricular Dysfunction, Previously Revascularized. | Biotech Hunter | Biotech Hunter